Faculty of Medicine and Dentistry
The goal of PMCOL 412 is to learn about the molecular basis of disorders of the nervous system, current therapies in use, as well as novel potential treatments that are in clinical trials or at the preclinical experimental stage. Research frontiers in pain and neurodegenerative disorders such as Alzheimer, Parkinson and Huntington's disease, amyotrophic lateral sclerosis and multiple sclerosis among others, will be explored. Novel therapeutic targets and the potential treatments of tomorrow will be discussed. Prerequisites: PMCOL 343 and 344 or 371 or ZOOL 342 or consent of instructor.
| Section | Capacity | Class times | Instructor(s) |
|---|---|---|---|
|
LECTURE A1
(47081) |
45 |
2024-09-03 - 2024-12-09 (MWF)
14:00 - 14:50
ECHA 2-140
|
Primary Instructor: Simonetta Sipione
|